US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist
  • 5.285
  • -0.105-1.95%
Trading Mar 13 13:35 ET
79.39MMarket Cap-1.08P/E (TTM)

Jasper Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-20.23%-62.6M
-28.25%-21.13M
-17.29%-14.05M
12.00%-11.68M
-52.26%-15.74M
-13.54%-52.07M
-30.31%-16.48M
-24.25%-11.98M
-41.86%-13.27M
27.28%-10.34M
Net income from continuing operations
-10.55%-71.27M
-46.68%-24.32M
-6.23%-18.64M
9.31%-14.58M
3.73%-13.73M
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
Operating gains losses
-98.09%11K
----
----
----
----
107.99%575K
--0
--0
--0
109.50%575K
Depreciation and amortization
23.92%1.37M
-13.43%245K
96.01%541K
8.73%299K
5.11%288K
13.64%1.11M
3.66%283K
2.99%276K
26.15%275K
26.85%274K
Other non cash items
22.44%491K
54.76%130K
146.05%105K
137.74%120K
-84.24%136K
107.44%401K
833.33%84K
31.33%-228K
40.00%-318K
119.02%863K
Change In working capital
-96.61%173K
158.40%831K
-52.89%1.94M
-31.37%1M
-480.66%-3.6M
886.29%5.1M
-21.52%-1.42M
129.53%4.12M
28.07%1.46M
139.20%946K
-Change in receivables
--0
--0
--0
--0
--0
200.00%663K
--0
--0
--0
--663K
-Change in prepaid assets
-376.79%-2.12M
-167.14%-1.87M
-131.55%-443K
-107.93%-28K
175.17%218K
145.83%767K
48.42%-700K
38.87%1.4M
-61.92%353K
-7.81%-290K
-Change in payables and accrued expense
-47.21%2.75M
489.34%2.76M
-14.98%2.48M
-4.46%1.01M
-560.71%-3.51M
495.59%5.2M
223.10%469K
205.87%2.92M
488.83%1.05M
136.82%761K
-Change in other current assets
189.55%523K
120.71%193K
341.18%150K
-7.14%260K
-335.29%-80K
-412.28%-584K
-331.48%-932K
0.00%34K
723.53%280K
0.00%34K
-Change in other current liabilities
-2.96%-973K
1.54%-256K
-4.66%-247K
-4.41%-237K
-4.95%-233K
-183.55%-945K
-117.98%-260K
-15.69%-236K
---227K
-100.00%-222K
Cash from discontinued investing activities
Operating cash flow
-20.23%-62.6M
-28.25%-21.13M
-17.29%-14.05M
12.00%-11.68M
-52.26%-15.74M
-13.54%-52.07M
-30.31%-16.48M
-24.25%-11.98M
-41.86%-13.27M
27.28%-10.34M
Investing cash flow
Cash flow from continuing investing activities
-99.25%-532K
66.96%-76K
-274K
-1,327.27%-157K
3.85%-25K
53.65%-267K
-180.49%-230K
0
95.47%-11K
10.34%-26K
Net PPE purchase and sale
-99.25%-532K
66.96%-76K
---274K
-1,327.27%-157K
3.85%-25K
53.65%-267K
-180.49%-230K
--0
95.47%-11K
10.34%-26K
Cash from discontinued investing activities
Investing cash flow
-99.25%-532K
66.96%-76K
---274K
-1,327.27%-157K
3.85%-25K
53.65%-267K
-180.49%-230K
--0
95.47%-11K
10.34%-26K
Financing cash flow
Cash flow from continuing financing activities
-52.58%47.88M
227.31%345K
-75.00%9K
159.34%181K
-53.36%47.35M
183,483.64%100.97M
-1,067.86%-271K
3,500.00%36K
-2,446.15%-305K
780,753.85%101.51M
Net common stock issuance
-53.49%47.2M
--0
--0
--0
-53.49%47.2M
--101.48M
--0
--0
--0
--101.48M
Proceeds from stock option exercised by employees
52.43%689K
1,132.14%345K
-75.00%9K
-49.16%181K
381.25%154K
721.82%452K
0.00%28K
3,500.00%36K
2,638.46%356K
146.15%32K
Net other financing activities
----
----
----
----
----
---960K
---299K
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-52.58%47.88M
227.31%345K
-75.00%9K
159.34%181K
-53.36%47.35M
183,483.64%100.97M
-1,067.86%-271K
3,500.00%36K
-2,446.15%-305K
780,753.85%101.51M
Net cash flow
Beginning cash position
125.78%87.3M
-10.90%92.92M
-7.74%107.24M
-8.42%118.89M
125.78%87.3M
-54.53%38.67M
103.02%104.28M
89.82%116.23M
83.31%129.82M
-54.53%38.67M
Current changes in cash
-131.35%-15.25M
-22.88%-20.87M
-19.86%-14.32M
14.22%-11.66M
-65.35%31.59M
204.87%48.64M
-33.70%-16.98M
-21.10%-11.95M
-41.75%-13.59M
740.59%91.15M
End cash Position
-17.47%72.05M
-17.47%72.05M
-10.90%92.92M
-7.74%107.24M
-8.42%118.89M
125.78%87.3M
125.78%87.3M
103.02%104.28M
89.82%116.23M
83.31%129.82M
Free cash flow
-20.67%-63.15M
-27.06%-21.23M
-19.57%-14.33M
10.89%-11.84M
-52.12%-15.76M
-12.71%-52.33M
-31.28%-16.71M
-21.45%-11.98M
-38.38%-13.28M
27.25%-10.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -20.23%-62.6M-28.25%-21.13M-17.29%-14.05M12.00%-11.68M-52.26%-15.74M-13.54%-52.07M-30.31%-16.48M-24.25%-11.98M-41.86%-13.27M27.28%-10.34M
Net income from continuing operations -10.55%-71.27M-46.68%-24.32M-6.23%-18.64M9.31%-14.58M3.73%-13.73M-71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M
Operating gains losses -98.09%11K----------------107.99%575K--0--0--0109.50%575K
Depreciation and amortization 23.92%1.37M-13.43%245K96.01%541K8.73%299K5.11%288K13.64%1.11M3.66%283K2.99%276K26.15%275K26.85%274K
Other non cash items 22.44%491K54.76%130K146.05%105K137.74%120K-84.24%136K107.44%401K833.33%84K31.33%-228K40.00%-318K119.02%863K
Change In working capital -96.61%173K158.40%831K-52.89%1.94M-31.37%1M-480.66%-3.6M886.29%5.1M-21.52%-1.42M129.53%4.12M28.07%1.46M139.20%946K
-Change in receivables --0--0--0--0--0200.00%663K--0--0--0--663K
-Change in prepaid assets -376.79%-2.12M-167.14%-1.87M-131.55%-443K-107.93%-28K175.17%218K145.83%767K48.42%-700K38.87%1.4M-61.92%353K-7.81%-290K
-Change in payables and accrued expense -47.21%2.75M489.34%2.76M-14.98%2.48M-4.46%1.01M-560.71%-3.51M495.59%5.2M223.10%469K205.87%2.92M488.83%1.05M136.82%761K
-Change in other current assets 189.55%523K120.71%193K341.18%150K-7.14%260K-335.29%-80K-412.28%-584K-331.48%-932K0.00%34K723.53%280K0.00%34K
-Change in other current liabilities -2.96%-973K1.54%-256K-4.66%-247K-4.41%-237K-4.95%-233K-183.55%-945K-117.98%-260K-15.69%-236K---227K-100.00%-222K
Cash from discontinued investing activities
Operating cash flow -20.23%-62.6M-28.25%-21.13M-17.29%-14.05M12.00%-11.68M-52.26%-15.74M-13.54%-52.07M-30.31%-16.48M-24.25%-11.98M-41.86%-13.27M27.28%-10.34M
Investing cash flow
Cash flow from continuing investing activities -99.25%-532K66.96%-76K-274K-1,327.27%-157K3.85%-25K53.65%-267K-180.49%-230K095.47%-11K10.34%-26K
Net PPE purchase and sale -99.25%-532K66.96%-76K---274K-1,327.27%-157K3.85%-25K53.65%-267K-180.49%-230K--095.47%-11K10.34%-26K
Cash from discontinued investing activities
Investing cash flow -99.25%-532K66.96%-76K---274K-1,327.27%-157K3.85%-25K53.65%-267K-180.49%-230K--095.47%-11K10.34%-26K
Financing cash flow
Cash flow from continuing financing activities -52.58%47.88M227.31%345K-75.00%9K159.34%181K-53.36%47.35M183,483.64%100.97M-1,067.86%-271K3,500.00%36K-2,446.15%-305K780,753.85%101.51M
Net common stock issuance -53.49%47.2M--0--0--0-53.49%47.2M--101.48M--0--0--0--101.48M
Proceeds from stock option exercised by employees 52.43%689K1,132.14%345K-75.00%9K-49.16%181K381.25%154K721.82%452K0.00%28K3,500.00%36K2,638.46%356K146.15%32K
Net other financing activities -----------------------960K---299K--0--------
Cash from discontinued financing activities
Financing cash flow -52.58%47.88M227.31%345K-75.00%9K159.34%181K-53.36%47.35M183,483.64%100.97M-1,067.86%-271K3,500.00%36K-2,446.15%-305K780,753.85%101.51M
Net cash flow
Beginning cash position 125.78%87.3M-10.90%92.92M-7.74%107.24M-8.42%118.89M125.78%87.3M-54.53%38.67M103.02%104.28M89.82%116.23M83.31%129.82M-54.53%38.67M
Current changes in cash -131.35%-15.25M-22.88%-20.87M-19.86%-14.32M14.22%-11.66M-65.35%31.59M204.87%48.64M-33.70%-16.98M-21.10%-11.95M-41.75%-13.59M740.59%91.15M
End cash Position -17.47%72.05M-17.47%72.05M-10.90%92.92M-7.74%107.24M-8.42%118.89M125.78%87.3M125.78%87.3M103.02%104.28M89.82%116.23M83.31%129.82M
Free cash flow -20.67%-63.15M-27.06%-21.23M-19.57%-14.33M10.89%-11.84M-52.12%-15.76M-12.71%-52.33M-31.28%-16.71M-21.45%-11.98M-38.38%-13.28M27.25%-10.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Trending Stocks

AI application software AI application software

AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc. AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc.

Unlock Now